Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-alfentanyl versus ketamine-alfentanyl for sedation during closed reduction of nasal bone fracture
IRCT20191127045530N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Dexmedetomidine + alfentanyl with Ketamine + alfentanyl (2 arms). Primary endpoints: VAS pain score, systolic blood pressure and 4 more. Started Nov 2019; status: completed.
02
Drugs
dexmedetomidinealfentanilketamine
Beyond the preview
Go deeper on IRCT20191127045530N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191127045530N1.